BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29756208)

  • 1. Impact of loss-of-function mutations at the RNF43 locus on colorectal cancer development and progression.
    Eto T; Miyake K; Nosho K; Ohmuraya M; Imamura Y; Arima K; Kanno S; Fu L; Kiyozumi Y; Izumi D; Sugihara H; Hiyoshi Y; Miyamoto Y; Sawayama H; Iwatsuki M; Baba Y; Yoshida N; Furukawa T; Araki K; Baba H; Ishimoto T
    J Pathol; 2018 Aug; 245(4):445-455. PubMed ID: 29756208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of endogenous RNF43 function enhances proliferation and tumour growth of intestinal and gastric cells.
    Neumeyer V; Grandl M; Dietl A; Brutau-Abia A; Allgäuer M; Kalali B; Zhang Y; Pan KF; Steiger K; Vieth M; Anton M; Mejías-Luque R; Gerhard M
    Carcinogenesis; 2019 Jun; 40(4):551-559. PubMed ID: 30380024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis.
    Bond CE; McKeone DM; Kalimutho M; Bettington ML; Pearson SA; Dumenil TD; Wockner LF; Burge M; Leggett BA; Whitehall VL
    Oncotarget; 2016 Oct; 7(43):70589-70600. PubMed ID: 27661107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors.
    Koo BK; Spit M; Jordens I; Low TY; Stange DE; van de Wetering M; van Es JH; Mohammed S; Heck AJ; Maurice MM; Clevers H
    Nature; 2012 Aug; 488(7413):665-9. PubMed ID: 22895187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers.
    Fennell LJ; Clendenning M; McKeone DM; Jamieson SH; Balachandran S; Borowsky J; Liu J; Kawamata F; Bond CE; Rosty C; Burge ME; Buchanan DD; Leggett BA; Whitehall VLJ
    Fam Cancer; 2018 Jan; 17(1):63-69. PubMed ID: 28573495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer.
    Yamamoto D; Oshima H; Wang D; Takeda H; Kita K; Lei X; Nakayama M; Murakami K; Ohama T; Takemura H; Toyota M; Suzuki H; Inaki N; Oshima M
    J Pathol; 2022 May; 257(1):39-52. PubMed ID: 35040131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent PTPRK-RSPO3 fusions and RNF43 mutations in colorectal traditional serrated adenoma.
    Sekine S; Yamashita S; Tanabe T; Hashimoto T; Yoshida H; Taniguchi H; Kojima M; Shinmura K; Saito Y; Hiraoka N; Ushijima T; Ochiai A
    J Pathol; 2016 Jun; 239(2):133-8. PubMed ID: 26924569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.
    Yan HHN; Lai JCW; Ho SL; Leung WK; Law WL; Lee JFY; Chan AKW; Tsui WY; Chan ASY; Lee BCH; Yue SSK; Man AHY; Clevers H; Yuen ST; Leung SY
    Gut; 2017 Sep; 66(9):1645-1656. PubMed ID: 27329244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNF43 Is an Early and Specific Mutated Gene in the Serrated Pathway, With Increased Frequency in Traditional Serrated Adenoma and Its Associated Malignancy.
    Tsai JH; Liau JY; Yuan CT; Lin YL; Tseng LH; Cheng ML; Jeng YM
    Am J Surg Pathol; 2016 Oct; 40(10):1352-9. PubMed ID: 27305845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commonly observed RNF43 mutations retain functionality in attenuating Wnt/β-catenin signaling and unlikely confer Wnt-dependency onto colorectal cancers.
    Li S; Lavrijsen M; Bakker A; Magierowski M; Magierowska K; Liu P; Wang W; Peppelenbosch MP; Smits R
    Oncogene; 2020 Apr; 39(17):3458-3472. PubMed ID: 32103169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulated Wnt signalling and recurrent mutations of the tumour suppressor RNF43 in early gastric carcinogenesis.
    Min BH; Hwang J; Kim NK; Park G; Kang SY; Ahn S; Ahn S; Ha SY; Lee YK; Kushima R; Van Vrancken M; Kim MJ; Park C; Park HY; Chae J; Jang SS; Kim SJ; Kim YH; Kim JI; Kim KM
    J Pathol; 2016 Nov; 240(3):304-314. PubMed ID: 27514024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent frameshift mutations in 2 mononucleotide repeats of RNF43 gene and its regional heterogeneity in gastric and colorectal cancers.
    Jo YS; Kim MS; Lee JH; Lee SH; An CH; Yoo NJ
    Hum Pathol; 2015 Nov; 46(11):1640-6. PubMed ID: 26297255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner.
    Hao HX; Xie Y; Zhang Y; Charlat O; Oster E; Avello M; Lei H; Mickanin C; Liu D; Ruffner H; Mao X; Ma Q; Zamponi R; Bouwmeester T; Finan PM; Kirschner MW; Porter JA; Serluca FC; Cong F
    Nature; 2012 Apr; 485(7397):195-200. PubMed ID: 22575959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNF43 is frequently mutated in colorectal and endometrial cancers.
    Giannakis M; Hodis E; Jasmine Mu X; Yamauchi M; Rosenbluh J; Cibulskis K; Saksena G; Lawrence MS; Qian ZR; Nishihara R; Van Allen EM; Hahn WC; Gabriel SB; Lander ES; Getz G; Ogino S; Fuchs CS; Garraway LA
    Nat Genet; 2014 Dec; 46(12):1264-6. PubMed ID: 25344691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brg-1 targeting of novel miR550a-5p/RNF43/Wnt signaling axis regulates colorectal cancer metastasis.
    Wang G; Fu Y; Yang X; Luo X; Wang J; Gong J; Hu J
    Oncogene; 2016 Feb; 35(5):651-61. PubMed ID: 25961913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNF43 interacts with NEDL1 and regulates p53-mediated transcription.
    Shinada K; Tsukiyama T; Sho T; Okumura F; Asaka M; Hatakeyama S
    Biochem Biophys Res Commun; 2011 Jan; 404(1):143-7. PubMed ID: 21108931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors.
    Steinhart Z; Pavlovic Z; Chandrashekhar M; Hart T; Wang X; Zhang X; Robitaille M; Brown KR; Jaksani S; Overmeer R; Boj SF; Adams J; Pan J; Clevers H; Sidhu S; Moffat J; Angers S
    Nat Med; 2017 Jan; 23(1):60-68. PubMed ID: 27869803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rnf43.
    Serra S; Chetty R
    J Clin Pathol; 2018 Jan; 71(1):1-6. PubMed ID: 29018044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer.
    Seeber A; Battaglin F; Zimmer K; Kocher F; Baca Y; Xiu J; Spizzo G; Novotny-Diermayr V; Rieder D; Puccini A; Swensen J; Ellis M; Goldberg RM; Grothey A; Shields AF; Marshall JL; Weinberg BA; Sackstein PE; Lim KH; Tan GS; Nabhan C; Korn WM; Amann A; Trajanoski Z; Berger MD; Lou E; Wolf D; Lenz HJ
    Clin Cancer Res; 2022 May; 28(9):1863-1870. PubMed ID: 35254413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ring finger protein 43 associates with gastric cancer progression and attenuates the stemness of gastric cancer stem-like cells via the Wnt-β/catenin signaling pathway.
    Gao Y; Cai A; Xi H; Li J; Xu W; Zhang Y; Zhang K; Cui J; Wu X; Wei B; Chen L
    Stem Cell Res Ther; 2017 Apr; 8(1):98. PubMed ID: 28446252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.